Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Rectal Neoplasms × Methods × Clear all

Phase

Status

Completed 6 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 8 Breast Neoplasms 6 Neoplasms 5 Lung Neoplasms 4 Colorectal Neoplasms 4 Melanoma 3 Anatomic Stage I Breast Cancer AJCC v8 3 Pancreatic Neoplasms 2 Hematologic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Tobacco Smoking 1 Testicular Neoplasms 1 Spondylitis, Ankylosing 1 Specific Learning Disorder 1 Smoking Cessation 1 Smoking 1 Signs and Symptoms 1 Sepsis 1 Sedentary Behavior 1 Sarcoma 1 Rectal Neoplasms 1 Psoriasis 1 Pancreatic Diseases 1 Pancreatic Cyst 1 Pain 1 Overweight 1 Orientation, Spatial 1 Obesity 1

Interventions

Capecitabine 24 Oxaliplatin 22 Radiotherapy 15 Fluorouracil 13 Surgical Procedures, Operative 11 Drug Therapy 8 Chemoradiotherapy 8 Bevacizumab 8 Leucovorin 7 Consolidation Chemotherapy 7 Radiation 6 XELOX 5 Specimen Handling 5 Irinotecan 5 Folfox protocol 5 spartalizumab 4 sintilimab 4 Neoadjuvant Therapy 4 trifluridine tipiracil drug combination 3 pembrolizumab 3 irinotecan sucrosofate 3 fludarabine 3 dehydroftorafur 3 Radiotherapy, Intensity-Modulated 3 Nivolumab 3 Mastectomy, Segmental 3 Magnetic Resonance Spectroscopy 3 Endoscopy 3 Cyclophosphamide 3 Cetuximab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04288999 2020-06-04

JCOG1801

National Cancer Center Hospital East

Phase 3 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡